Differentiation and function of osteoclasts

Keio Journal of Medicine

Volumn 52, Issue 1, 2003, Pages 1-7

  Miyamoto, Takeshi ^a   Suda, Toshio ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Bone resorption; Differentiation; Osteoclast

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ALBERS SCHOENBERG DISEASE; BLOOD CELL; BONE DESTRUCTION; BONE MARROW; BONE METASTASIS; CANCER CELL; CELL DIFFERENTIATION; CELL FUNCTION; COLONY FORMING UNIT M; HEMATOPOIESIS; HOMEOSTASIS; HYPERCALCEMIA; IN VITRO STUDY; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOSCLEROSIS; REVIEW; STEM CELL; CYTOLOGY; HUMAN; PATHOLOGY; PHYSIOLOGY;

BONE RESORPTION; CELL DIFFERENTIATION; HUMANS; OSTEOCLASTS;

EID: 0037362364     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.52.1     Document Type: Review

References (20)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
2. Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, Iijima S, Suzuki F, Kondo J: Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997; 272: 32419-32426
3. Nesbitt SA, Horton MA: Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997; 276: 266-269
4. Ash P, Loutit JF, Townsend KM: Osteoclasts derived from haematopoietic stem cells. Nature 1980; 283: 669-670
5. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T: Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 2001; 98: 2544-2554
6. Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M, Naito M, Takahashi K: Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996; 88: 4029-4039
7. Baron R, Neff L, Tran Van P, Nefussi JR, Vignery A: Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 1986; 122: 363-378
8. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T: The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989; 125: 1805-1813
9. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T: Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988; 123: 2600-2602
10. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 390: 175-179
11. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, et al: Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-3602
12. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-176
13. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS 3rd, Frankel WN, et al: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997; 272: 25190-25194
14. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y: TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997; 186: 2075-2080
15. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et al: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319
16. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K: Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997; 234: 137-142
17. Miyamoto T, Arai F, Ohneda O, Takagi K, Anderson DM, Suda T: An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 2000; 96: 4335-4343
18. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T: Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999; 190: 1741-1754
19. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, et al: RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002; 416: 744-749
20. Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M: Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood 2002; 99: 634-640